Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1191201012 | Doxorubicin hydrochloride 50mg injection (pdr for recon) (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 1763447013 | Doxorubicin hydrochloride 50mg powder for injection solution vial (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 1775853015 | Doxorubicin hydrochloride 50mg powder for injection solution vial | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 1785196018 | Doxorubicin hydrochloride 50mg/vil injection | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3689644011 | Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3689645012 | Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3689646013 | Doxorubicin hydrochloride 50 mg powder for solution for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 466563012 | Doxorubicin hydrochloride 50mg injection (pdr for recon) | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 719194010 | Doxorubicin hydrochloride 50mg injection (pdr for recon) (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Is a | Doxorubicin only product in parenteral dose form | true | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Is a | Doxorubicin-containing product | false | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has active ingredient | Doxorubicin hydrochloride | false | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Is a | Doxorubicin-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has BoSS | Doxorubicin hydrochloride | true | Inferred relationship | Some | 1 | |
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has presentation strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has precise active ingredient | Doxorubicin hydrochloride | true | Inferred relationship | Some | 1 | |
| Doxorubicin hydrochloride 50 mg powder for solution for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR